1,1'-diethyl-2,2'-cyanine chloride : no description available [CHeBI]
ID Source | ID |
---|---|
PubMed CID | 5717105 |
CHEMBL ID | 576409 |
CHEBI ID | 38004 |
MeSH ID | M0327493 |
Synonym |
---|
2,2'-quinocyanine chloride |
1,2'-cyanine chloride |
n,n'-diethylpseudoisocyanine |
nsc97374 |
diethylcyanine |
2,2'-cyanine chloride |
pseudoisocyanine chloride |
2402-42-8 |
pseudoisocyanine diethyl chloride |
n,n'-diethylpseudoisocyanine chloride |
1-ethyl-2-[(1-ethyl-2(1h)-quinolinylidene)methyl]quinolinium chloride |
1,1'-diethyl-2,2'-cyanine chloride |
CHEBI:38004 , |
1-ethyl-2-{[1-ethylquinolin-2(1h)-ylidene]methyl}quinolinium chloride |
CHEMBL576409 |
AKOS003601262 |
HMS2172F09 |
quinolinium, 1-ethyl-2-((1-ethyl-2(1h)-quinolinylidene)methyl)-, chloride |
einecs 219-279-7 |
1-ethyl-2-((1-ethyl-1,2-dihydro-2-quinolylidene)methyl)quinoliniumchloride |
unii-vxj7avj43d |
nsc 97374 |
vxj7avj43d , |
quinolinium, 1-ethyl-2-((1-ethyl-2(1h)-quinolinylidene)methyl)-, chloride (1:1) |
(2e)-1-ethyl-2-[(1-ethylquinolin-1-ium-2-yl)methylidene]quinoline;chloride |
SR-01000391515-1 |
sr-01000391515 |
Q27117339 |
nsc-97374 chloride |
1-ethyl-2-((1-ethyl-2(1h)-quinolylidene)methyl)quinolinium chloride |
quinolinium,1-ethyl-2-[(1-ethyl-2(1h)-quinolinylidene)methyl]-,chloride |
Class | Description |
---|---|
1,1'-diethyl-2,2'-cyanine halide | |
organic chloride salt |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) |
---|---|---|---|---|
Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 35.4813 | AID504339 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 44.9647 | AID2549; AID504841 |
Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 19.9526 | AID485281 |
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 21.3313 | AID588342 |
glp-1 receptor, partial | Homo sapiens (human) | Potency | 5.5756 | AID624172; AID624417 |
thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 56.2341 | AID588453 |
BRCA1 | Homo sapiens (human) | Potency | 3.9811 | AID624202 |
WRN | Homo sapiens (human) | Potency | 44.6684 | AID651768 |
phosphopantetheinyl transferase | Bacillus subtilis | Potency | 50.1187 | AID1490 |
ATAD5 protein, partial | Homo sapiens (human) | Potency | 9.2000 | AID504467 |
USP1 protein, partial | Homo sapiens (human) | Potency | 28.1838 | AID743255 |
TDP1 protein | Homo sapiens (human) | Potency | 1.5470 | AID686978; AID686979 |
Microtubule-associated protein tau | Homo sapiens (human) | Potency | 3.1623 | AID1460 |
thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 7.9433 | AID485364 |
Smad3 | Homo sapiens (human) | Potency | 1.7783 | AID588855 |
apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 22.3872 | AID720542 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 28.1838 | AID1030 |
PINK1 | Homo sapiens (human) | Potency | 2.8184 | AID624263 |
hypothetical protein, conserved | Trypanosoma brucei | Potency | 18.9895 | AID624173; AID720569; AID720584 |
nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 3.9811 | AID2326 |
67.9K protein | Vaccinia virus | Potency | 12.5893 | AID720580 |
Parkin | Homo sapiens (human) | Potency | 2.8184 | AID624263 |
bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 70.7946 | AID504333 |
pyruvate kinase | Leishmania mexicana mexicana | Potency | 14.1254 | AID1721; AID1722 |
IDH1 | Homo sapiens (human) | Potency | 6.5131 | AID686970 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 11.2202 | AID504332 |
chromobox protein homolog 1 | Homo sapiens (human) | Potency | 17.7828 | AID540317 |
nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 2.9093 | AID504444 |
transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 25.1189 | AID624246 |
huntingtin isoform 2 | Homo sapiens (human) | Potency | 3.1623 | AID1688 |
importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 89.1251 | AID540263 |
pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 14.1254 | AID1631; AID1634 |
DNA polymerase beta | Homo sapiens (human) | Potency | 15.8489 | AID485314 |
flap endonuclease 1 | Homo sapiens (human) | Potency | 39.8107 | AID588795 |
ras-related protein Rab-9A | Homo sapiens (human) | Potency | 0.7943 | AID485297 |
snurportin-1 | Homo sapiens (human) | Potency | 89.1251 | AID540263 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 89.1251 | AID2662 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 84.9214 | AID504891 |
tumor susceptibility gene 101 protein | Homo sapiens (human) | Potency | 56.2341 | AID493005 |
DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 12.5893 | AID588591 |
nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 5.8654 | AID2546; AID2551 |
DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 79.4328 | AID588579 |
Vpr | Human immunodeficiency virus 1 | Potency | 22.3872 | AID651644 |
survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 1.5849 | AID1458 |
muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 3.9811 | AID2675 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | Potency | 16.5044 | AID602310; AID651812; AID651813 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 12.5893 | AID602313 |
lamin isoform A-delta10 | Homo sapiens (human) | Potency | 5.6234 | AID1487 |
neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 7.9433 | AID1461 |
Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 56.2341 | AID720709 |
Endothelin receptor type B | Rattus norvegicus (Norway rat) | Potency | 14.1254 | AID1721 |
Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Potency | 14.1254 | AID1721 |
Alpha-synuclein | Homo sapiens (human) | Potency | 11.2202 | AID652106 |
Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 10.6101 | AID1457; AID901 |
TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 10.0000 | AID652104 |
phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 26.0988 | AID602233; AID686980 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) |
---|---|---|---|---|
nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | IC50 | 12.8460 | AID504329 |
sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | IC50 | 2.0925 | AID851; AID856 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | IC50 | 33.7653 | AID855 |
eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | IC50 | 33.7653 | AID855 |
rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | IC50 | 46.4600 | AID624330 |
alkaline phosphatase, germ cell type preproprotein | Homo sapiens (human) | IC50 | 10.6000 | AID690 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) |
---|---|---|---|---|
alkaline phosphatase, germ cell type preproprotein | Homo sapiens (human) | EC50 | 999.0000 | AID696 |
streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 78.0425 | AID1902; AID1914 |
Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | AID1914 |
Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | AID1914 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) |
---|---|---|---|---|
glycogen synthase kinase-3 alpha | Homo sapiens (human) | AC50 | 66.1400 | AID463203 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Inflammation | 0 | 2010 | 2010 | 14.0 | high | 0 | 0 | 0 | 1 | 0 | 0 | |
Innate Inflammatory Response | 0 | 2010 | 2010 | 14.0 | high | 0 | 0 | 0 | 1 | 0 | 0 |